Arch Venture Management, Llc Portfolio Stock Holdings
Arch Venture Management, Llc disclosed 10 stock positions valued at approximately $677.1 million in its latest SEC 13F filing. The largest holdings include RAPPORT THERAPEUTICS INC, VIR BIOTECHNOLOGY INC, and ERASCA INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 10
- Portfolio Value
- $677.1M
Holdings by Sector
Arch Venture Management, Llc Portfolio Holdings in Q1 2026
7 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| RAPPORT THERAPEUTICS INC | RAPP | Healthcare | 17.23% | 3,728,738 | - | - | $116,672,212 |
| VIR BIOTECHNOLOGY INC | VIR | Healthcare | 17.09% | 12,916,663 | - | - | $115,733,300 |
| ERASCA INC | ERAS | Healthcare | 16.95% | 7,091,557 | -3,963,997 | -35.86% | $114,741,392 |
| BEAM THERAPEUTICS INC | BEAM | Healthcare | 15.98% | 4,540,132 | - | - | $108,191,346 |
| 10X GENOMICS INC | TXG | Healthcare | 0.68% | 217,834 | -519,705 | -70.46% | $4,624,616 |
| GOSSAMER BIO INC | GOSS | Healthcare | 0.39% | 8,055,916 | - | - | $2,646,368 |
| Q32 BIO INC | QTTB | Healthcare | 0.30% | 320,482 | - | - | $2,057,494 |